Dice Therapeutics Inc.

Dice Therapeutics Inc.

World Rank (Aug-2026)
5326
World Rank (Jan-05-2024)
5,326
World Rank (Jul-30-2023)
5,326
Market Cap (Jul-30-2023)
2.244 Billion USD
World Rank (Jan-07-2022)
10,632
Market Cap (Jan-07-2022)
0.807 Billion USD
Headquarters Country
USA
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-88 Million USD
Annual Net Income in USD
-84 Million USD
Annual Results for Period Ending
For year ending December-2022
Total Assets in USD
594 Million USD
Total Liabilities in USD
27 Million USD
Total Equity in USD
567 Million USD
Balance Sheet for Period Ending
As of December-2022
Business Sector
Biopharmaceutical
Healthcare
Company Profile

DICE THERAPEUTICS is a Biopharmaceutical company with headquarters is in USA.

DICE THERAPEUTICS is developing transformative medicines for autoimmune and inflammatory diseases.

ELI LILLY COMPANY acquired DICE THERAPEUTICS, INC for 2.4 billion USD.

IPO Year
2021
Stock Exchange
Nasdaq

Share